These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 24768944)
1. Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells. Nickel A; Stadler SC Transl Res; 2015 Jan; 165(1):126-42. PubMed ID: 24768944 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Wang Y; Shang Y Exp Cell Res; 2013 Jan; 319(2):160-9. PubMed ID: 22935683 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of epithelial-mesenchymal transition. Sun L; Fang J Cell Mol Life Sci; 2016 Dec; 73(23):4493-4515. PubMed ID: 27392607 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition. Carmona FJ; Davalos V; Vidal E; Gomez A; Heyn H; Hashimoto Y; Vizoso M; Martinez-Cardus A; Sayols S; Ferreira HJ; Sánchez-Mut JV; Morán S; Margelí M; Castella E; Berdasco M; Stefansson OA; Eyfjord JE; Gonzalez-Suarez E; Dopazo J; Orozco M; Gut IG; Esteller M Cancer Res; 2014 Oct; 74(19):5608-19. PubMed ID: 25106427 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011 [TBL] [Abstract][Full Text] [Related]
6. A prospective epigenetic paradigm between cellular senescence and epithelial-mesenchymal transition in organismal development and aging. Kishi S; Bayliss PE; Hanai J Transl Res; 2015 Jan; 165(1):241-9. PubMed ID: 24924348 [TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic aspects of breast cancer progression and therapy. Byler S; Goldgar S; Heerboth S; Leary M; Housman G; Moulton K; Sarkar S Anticancer Res; 2014 Mar; 34(3):1071-7. PubMed ID: 24596345 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of epithelial to mesenchymal transition. Huangyang P; Shang Y Curr Cancer Drug Targets; 2013 Nov; 13(9):973-85. PubMed ID: 24168185 [TBL] [Abstract][Full Text] [Related]
9. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents. Pogribny IP; Tryndyak VP; Pogribna M; Shpyleva S; Surratt G; Gamboa da Costa G; Beland FA Int J Oncol; 2013 May; 42(5):1822-32. PubMed ID: 23483119 [TBL] [Abstract][Full Text] [Related]
11. The landscape of histone acetylation involved in epithelial-mesenchymal transition in lung cancer. Zhang L; Liu Z; Ma W; Wang B J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S86-91. PubMed ID: 24135248 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Wu CY; Tsai YP; Wu MZ; Teng SC; Wu KJ Trends Genet; 2012 Sep; 28(9):454-63. PubMed ID: 22717049 [TBL] [Abstract][Full Text] [Related]
13. Global and gene specific DNA methylation in breast cancer cells was not affected during epithelial-to-mesenchymal transition in vitro. Smolkova B; Miklikova S; Kajabova VH; Babelova A; Yamani NE; Zduriencikova M; Fridrichova I; Zmetakova I; Krivulcik T; Kalinkova L; Matuskova M; Kucerova L; Dusinska M Neoplasma; 2016; 63(6):901-910. PubMed ID: 27565328 [TBL] [Abstract][Full Text] [Related]
14. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression. Mishra VK; Johnsen SA Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulatory mechanisms during preimplantation development. Corry GN; Tanasijevic B; Barry ER; Krueger W; Rasmussen TP Birth Defects Res C Embryo Today; 2009 Dec; 87(4):297-313. PubMed ID: 19960551 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms of breast cancer: an update of the current knowledge. Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic reprogramming in breast cancer: from new targets to new therapies. Katz TA; Huang Y; Davidson NE; Jankowitz RC Ann Med; 2014 Sep; 46(6):397-408. PubMed ID: 25058177 [TBL] [Abstract][Full Text] [Related]
18. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic Modulations in Breast Cancer: An Emerging Paradigm in Therapeutic Implications. Sarkar S; Venkatesh D; Kandasamy T; Ghosh SS Front Biosci (Landmark Ed); 2024 Aug; 29(8):287. PubMed ID: 39206915 [TBL] [Abstract][Full Text] [Related]
20. Interplay between different epigenetic modifications and mechanisms. Murr R Adv Genet; 2010; 70():101-41. PubMed ID: 20920747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]